Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P220003/S029

PASCAL Precision Transcatheter Valve Repair System

Edwards Lifesciences, LLC · Decision date Oct 20, 2026

FDA DECISIONP220003/S029

What did the FDA approve?

FDA records P220003/S029 as a supplement to PMA P220003, with the supplement type “Panel Track”. The recorded decision is approval, dated Oct 20, 2026.

FDA approval order statement

Approval for the Edwards PASCAL Precision Transcatheter Valve Repair System for expanding the indications to include patients with tricuspid regurgitation. This device is indicated for improving quality of life and functional status in patients with symptomatic severe tricuspid regurgitation despite optimal medical therapy who are deemed at intermediate or greater risk for surgery and deemed appropriate for transcatheter edge-to-edge tricuspid valve repair by a multidisciplinary heart team.
Regulatory pathway
PMA supplement
Supplement type
Panel Track
Clinical specialty
Cardiovascular
Decision date
Oct 20, 2026
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P220003/S029
Regulatory pathway
PMA supplement
Product code
NPS
Decision code
APPR
Decision date
Oct 20, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tricuspid valve repair device, percutaneously delivered.

Product code
NPS
FDA device class
3

For the original device and its historical approval scope, see PMA P220003. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P220003 · Original PMA

    PASCAL Precision Transcatheter Valve Repair System

  2. P220003/S029 received

    Application receipt date recorded by FDA.

  3. P220003/S033 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

  4. P220003/S028 · Related supplement

    PASCAL Ace with Capture Clarity Valve Repair System MR Implant System

  5. P220003/S029 · FDA decision

    Panel Track

  6. P220003/S032 · Related supplement

    PASCAL Precision Transcatheter Valve Repair System

Timeline entries are records held by MedtechLedger for P220003. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P220003

Explore the linked device profile

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Edwards Lifesciences, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
One Edwards Way, Irvine, CA, 92614

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records